Objective
The European Randomised Study of Screening for Prostate Cancer (ERSPC) aims at establishing of excluding an effect of population screening and early treatment on prostate cancer mortality (which is second to lung cancer in most EU countries) and on related quality of life and cost. A consortium of 7 EU countries and 2 candidate participants runs this study. It is ongoing since 1994 and about 150,000 men were randomised so far. Recrutment and re-screening will be concluded during 2003. This proposal covers the following aspects: the international co-ordination, the central database (not data collection) and quality control as well as the expenses of the Scientific Committee, Data Monitoring Committee, Epidemiology Committee, Causes of Death Committee, Pathology Committee and PSA Standardisation Committee. AII data collection and screening is funded locally per country. This study will result eventually in solid advice to health care policy makers in all European countries regarding the value of screening for prostate cancer.
Fields of science (EuroSciVoc)
CORDIS classifies projects with EuroSciVoc, a multilingual taxonomy of fields of science, through a semi-automatic process based on NLP techniques.
CORDIS classifies projects with EuroSciVoc, a multilingual taxonomy of fields of science, through a semi-automatic process based on NLP techniques.
- medical and health sciencesclinical medicineoncologyprostate cancer
- social sciencessociologydemographymortality
- medical and health sciencesclinical medicineoncologylung cancer
- medical and health scienceshealth sciencespublic healthepidemiology
- medical and health sciencesbasic medicinepathology
You need to log in or register to use this function
Call for proposal
Data not availableFunding Scheme
CON - Coordination of research actionsCoordinator
3000 DR ROTTERDAM
Netherlands